BioCentury
ARTICLE | Company News

Atrix, Fujisawa deal

December 23, 2002 8:00 AM UTC

Fujisawa exercised its option to explore additional indications for ATRX's topical Atrisone dapsone. Under the original deal, Fujisawa licensed exclusive North American marketing rights for the acne ...